Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Aeterna Zentaris (AEZS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 26,797
  • Shares Outstanding, K 16,440
  • Annual Sales, $ 920 K
  • Annual Income, $ -16,800 K
  • 36-Month Beta 1.26
  • Price/Sales 29.39
  • Price/Cash Flow N/A
  • Price/Book 2.85

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate -0.25
  • Number of Estimates 1
  • High Estimate -0.25
  • Low Estimate -0.25
  • Prior Year -0.44
  • Growth Rate Est. (year over year) +43.18%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.60 +8.75%
on 09/14/18
1.90 -8.42%
on 08/24/18
-0.08 (-4.40%)
since 08/20/18
3-Month
1.60 +8.75%
on 09/14/18
2.22 -21.62%
on 06/21/18
-0.46 (-20.91%)
since 06/20/18
52-Week
1.12 +55.36%
on 04/04/18
3.25 -46.46%
on 12/21/17
-0.41 (-19.07%)
since 09/20/17

Most Recent Stories

More News
Aeterna Zentaris to Announce Second Quarter 2018 Financial and Operating Results on August 9, 2018

Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX: AEZS) will announce its second quarter 2018 financial and operating results after market close on Thursday, August 9, 2018. The Company will host a conference...

AEZS.TO : 2.25 (+7.14%)
AEZS : 1.74 (+6.75%)
Inovio Pharmaceuticals (INO) in Focus: Stock Moves 5.7% Higher

Inovio Pharmaceuticals (INO) was a big mover last session, as the company saw its shares rise nearly 6% on the day.

AEZS : 1.74 (+6.75%)
INO : 4.89 (+1.45%)
Zacks.com highlights: Weight Watchers International, Aeterna Zentaris, TransUnion, Six Flags Entertainment and Johnson Outdoors

Zacks.com highlights: Weight Watchers International, Aeterna Zentaris, TransUnion, Six Flags Entertainment and Johnson Outdoors

SIX : 67.44 (+0.18%)
AEZS : 1.74 (+6.75%)
TRU : 75.53 (+1.83%)
JOUT : 94.27 (-0.40%)
WTW : 70.86 (+2.27%)
5 Top Profitable Stocks With Terrific Growth in the Offing

A company with a high level of profitability is able to meet all its operating and non-operating costs and expenses, and still provides high returns to its investors.

SIX : 67.44 (+0.18%)
AEZS : 1.74 (+6.75%)
TRU : 75.53 (+1.83%)
JOUT : 94.27 (-0.40%)
WTW : 70.86 (+2.27%)
Aeterna Zentaris Announces Results of Annual and Special Shareholders' Meeting

Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) announced today at its annual and special shareholders' meeting held on May 8, 2018, that the individuals noted below were elected as directors of the Company....

NVDQ : 11.75 (unch)
AEZS.TO : 2.25 (+7.14%)
AEZS : 1.74 (+6.75%)
NDQ.TO : 14.36 (+0.70%)
CECE : 8.23 (+1.86%)
Aeterna Zentaris Reports First Quarter 2018 Financial and Operating Results

Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) today reported financial and operating results for the first quarter ended March 31, 2018.

AEZS.TO : 2.25 (+7.14%)
AEZS : 1.74 (+6.75%)
Aeterna Zentaris to Announce First Quarter 2018 Financial and Operating Results on May 7, 2018

Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) will announce its first quarter 2018 financial and operating results after market close on Monday, May 7, 2018. The Company will host a conference call to...

AEZS.TO : 2.25 (+7.14%)
AEZS : 1.74 (+6.75%)
Aeterna Zentaris Files Management Information Circular

Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) is pleased to announce that it has filed its Management Information Circular for the upcoming Annual and Special Meeting of Shareholders. The Meeting will...

AEZS.TO : 2.25 (+7.14%)
AEZS : 1.74 (+6.75%)
Aeterna Zentaris Reports Fourth Quarter and Full-Year 2017 Financial and Operating Results

Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) today reported financial and operating results for the fourth quarter and year ended December 31, 2017.

AEZS.TO : 2.25 (+7.14%)
AEZS : 1.74 (+6.75%)
Aeterna Zentaris to Announce Fourth Quarter and Year End 2017 Financial and Operating Results on March 28th, 2018

Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) will announce its fourth quarter and year ended December 31, 2017 financial and operating results after market close on Tuesday, March 27, 2018. The Company...

AEZS.TO : 2.25 (+7.14%)
AEZS : 1.74 (+6.75%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade AEZS with:

Business Summary

AEterna Zentaris Inc. is a biopharmaceutical company focused on endocrine therapy and oncology. Its lead endocrinology program is a Phase 3 trial in benign prostatic hyperplasia (BPH) with cetrorelix, an LHRH antagonist already marketed for in vitro fertilization under the brand name Cetrotide. The lead...

See More

Key Turning Points

2nd Resistance Point 1.70
1st Resistance Point 1.66
Last Price 1.74
1st Support Level 1.60
2nd Support Level 1.58

See More

52-Week High 3.25
Fibonacci 61.8% 2.44
Fibonacci 50% 2.18
Fibonacci 38.2% 1.93
Last Price 1.74
52-Week Low 1.12

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar